256 related articles for article (PubMed ID: 24261363)
1. Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone?
Song JH; Grand DJ; Beland MD; Chang KJ; Machan JT; Mayo-Smith WW
AJR Am J Roentgenol; 2013 Dec; 201(6):1248-53. PubMed ID: 24261363
[TBL] [Abstract][Full Text] [Related]
2. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients.
Boland GW; Blake MA; Holalkere NS; Hahn PF
AJR Am J Roentgenol; 2009 Apr; 192(4):956-62. PubMed ID: 19304700
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between small benign and malignant adrenal masses with dynamic incremented CT.
Berland LL; Koslin DB; Kenney PJ; Stanley RJ; Lee JY
AJR Am J Roentgenol; 1988 Jul; 151(1):95-101. PubMed ID: 3259826
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT.
Sasaguri K; Takahashi N; Takeuchi M; Carter RE; Leibovich BC; Kawashima A
AJR Am J Roentgenol; 2016 Nov; 207(5):1031-1038. PubMed ID: 27556736
[TBL] [Abstract][Full Text] [Related]
5. The incidental indeterminate adrenal mass on CT (> 10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses.
Song JH; Chaudhry FS; Mayo-Smith WW
AJR Am J Roentgenol; 2007 Nov; 189(5):1119-23. PubMed ID: 17954649
[TBL] [Abstract][Full Text] [Related]
6. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
7. MDCT of adrenal masses: Can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma?
Northcutt BG; Raman SP; Long C; Oshmyansky AR; Siegelman SS; Fishman EK; Johnson PT
AJR Am J Roentgenol; 2013 Oct; 201(4):834-9. PubMed ID: 24059372
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of incidentally detected adrenal masses revealed on routine abdominal CT.
Ctvrtlík F; Herman M; Student V; Tichá V; Minarík J
Eur J Radiol; 2009 Feb; 69(2):243-52. PubMed ID: 18226485
[TBL] [Abstract][Full Text] [Related]
9. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.
Blake MA; Kalra MK; Sweeney AT; Lucey BC; Maher MM; Sahani DV; Halpern EF; Mueller PR; Hahn PF; Boland GW
Radiology; 2006 Feb; 238(2):578-85. PubMed ID: 16371582
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced sonography of adrenal masses: differentiation of adenomas and nonadenomatous lesions.
Friedrich-Rust M; Schneider G; Bohle RM; Herrmann E; Sarrazin C; Zeuzem S; Bojunga J
AJR Am J Roentgenol; 2008 Dec; 191(6):1852-60. PubMed ID: 19020259
[TBL] [Abstract][Full Text] [Related]
12. Characterization of adnexal masses using feature analysis at contrast-enhanced helical computed tomography.
Zhang J; Mironov S; Hricak H; Ishill NM; Moskowitz CS; Soslow RA; Chi DS
J Comput Assist Tomogr; 2008; 32(4):533-40. PubMed ID: 18664838
[TBL] [Abstract][Full Text] [Related]
13. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience.
Blake MA; Slattery JM; Kalra MK; Halpern EF; Fischman AJ; Mueller PR; Boland GW
Radiology; 2006 Mar; 238(3):970-7. PubMed ID: 16505394
[TBL] [Abstract][Full Text] [Related]
14. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
15. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT.
Peña CS; Boland GW; Hahn PF; Lee MJ; Mueller PR
Radiology; 2000 Dec; 217(3):798-802. PubMed ID: 11110946
[TBL] [Abstract][Full Text] [Related]
16. Dual-energy CT for characterization of the incidental adrenal mass: preliminary observations.
Gnannt R; Fischer M; Goetti R; Karlo C; Leschka S; Alkadhi H
AJR Am J Roentgenol; 2012 Jan; 198(1):138-44. PubMed ID: 22194489
[TBL] [Abstract][Full Text] [Related]
17. The adrenal mass: correlation of histopathology with imaging.
Yip L; Tublin ME; Falcone JA; Nordman CR; Stang MT; Ogilvie JB; Carty SE; Yim JH
Ann Surg Oncol; 2010 Mar; 17(3):846-52. PubMed ID: 19960266
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasound for imaging of adrenal masses.
Dietrich CF; Ignee A; Barreiros AP; Schreiber-Dietrich D; Sienz M; Bojunga J; Braden B
Ultraschall Med; 2010 Apr; 31(2):163-8. PubMed ID: 19401979
[TBL] [Abstract][Full Text] [Related]
19. Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound.
Friedrich-Rust M; Glasemann T; Polta A; Eichler K; Holzer K; Kriener S; Herrmann E; Nierhoff J; Bon D; Bechstein WO; Vogl T; Zeuzem S; Bojunga J
Ultraschall Med; 2011 Oct; 32(5):460-71. PubMed ID: 21667434
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT in the evaluation of adrenal masses.
Metser U; Miller E; Lerman H; Lievshitz G; Avital S; Even-Sapir E
J Nucl Med; 2006 Jan; 47(1):32-7. PubMed ID: 16391184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
